Named Patient Supply - Licenced Medicines Access Program ...

The Named Patient Program (NPP) provides patients and doctors with commercially approved drugs that are not available in their home country. ... is approved and available in one country, but not approved in the country where the patient is located. Discontinued in the country where the patient is located but not in other countries

Naming patient plan

Alleviare Life Sciences Pvt. Ltd. is a consulting pharmaceutical company that specializes in naming patients. We assist patients to establish contact with real and authorized distributors of special medicines that are not or not approved in India.

Indian generic drugs

If some patients require certain high-quality generic drugs, we will also abide by the highest ethical standards in the way of operation, we will provide a variety of options, and we can provide you with professional convenience.

Provide medicines to patients in need through designated patient supply

Governments around the world have established relevant provisions that allow patients who have exhausted all alternative treatment options and do not meet the criteria for clinical trial entry to use the prescribed patient drug treatment plan before they are approved. These named patient plans are usually categorized by sympathetic use, expanded use, or designated patient supply labels. These rules are governed by national / regional definitions of access standards, data collection, promotion, and drug distribution

 control rules.

Information for patients

What is the procedure for naming patients?

The Named Patient Program (NPP) provides patients and doctors with commercially approved drugs that are not available in their home country. These drugs must be approved in at least one country before they can be imported into the country where the patient is based on NPP.

The medicine is called 2 names?

Many drugs have at least two different names:

Brand name-created by pharmaceutical companies that manufacture drugs.

Generic name – the name of the active ingredient in the medicine.

Use of compassion in medicine

Sympathetic drug use (or sometimes sympathetic drug use) refers to the use of unapproved new drugs to treat critically ill patients when no other treatment is available. Drugs that are being tested but not yet approved by the US Food and Drug Administration (FDA) are called research drugs.

Special license

Special drugs refer to unlicensed drugs that can meet the individual clinical needs of patients when there are no suitable licensed drugs. "Special drugs" account for about 1% of all prescription drugs in the UK, but account for more than 75,000 different prescription drugs.

If you want to get more information  Click here